Welcome to our dedicated page for Blackstone news (Ticker: BX), a resource for investors and traders seeking the latest updates and insights on Blackstone stock.
Blackstone Inc (BX), the world's largest alternative asset manager, provides investors with transformative opportunities across private equity, real estate, and credit markets. This dedicated news hub delivers essential updates directly from corporate sources and trusted financial publications.
Access real-time announcements including quarterly earnings reports, strategic acquisitions, and leadership developments. Our curated feed simplifies tracking Blackstone's global investment activities across infrastructure, life sciences, and sustainability initiatives.
Key updates cover:
- Financial performance and dividend declarations
- Portfolio company milestones and exits
- Regulatory filings and compliance updates
- Industry analysis impacting alternative assets
Bookmark this page for streamlined monitoring of Blackstone's market position and strategic direction. Combine our timely updates with fundamental analysis tools for comprehensive investment research.
Blackstone (NYSE: BX) has announced the pricing of a $600 million offering of 5.900% senior notes due 2027 and $900 million of 6.200% senior notes due 2033. These notes will be fully guaranteed by Blackstone and its subsidiaries. The proceeds from this offering are intended for general corporate purposes. The notes will be sold to qualified institutional buyers under Rule 144A and Regulation S, though they are not registered under the Securities Act of 1933 and cannot be sold in the U.S. without registration or exemption.
Blackstone (NYSE: BX) announced plans to offer senior notes through its subsidiary, Blackstone Holdings Finance Co. L.L.C. The notes will be guaranteed by Blackstone and its indirect subsidiaries. Proceeds from the offering will be used for general corporate purposes. The notes are intended for sale to qualified institutional buyers under Rule 144A in the U.S. and outside the U.S. under Regulation S. These notes have not been registered under the Securities Act of 1933 and cannot be sold without registration or an exemption.
PTC Therapeutics has entered a strategic financing collaboration with Blackstone, securing up to $500 million in funding to enhance its product pipeline and business development. This includes $350 million in low-cost capital at the close. The funds will help accelerate PTC's mission to deliver transformative medicines, with a goal of launching one therapy every 2-3 years. Blackstone's investment will be collateralized by PTC's existing products, including Translarna™ and Upstaza®. The collaboration aims to optimize capital structure and support new medicines.
Blackstone (NYSE: BX) has announced a partnership with Dominium to develop the Aviara Flats community in Phoenix, Arizona, contributing
DNAnexus announced the appointment of Jeff Margolis to its Board of Directors. Margolis, a veteran in healthcare technology, has extensive experience in guiding companies from startup to leadership. His role follows DNAnexus securing
Blackstone (NYSE: BX) and Resolution Life have formed a strategic partnership to enhance growth in the global life and annuity market. The collaboration will manage up to
Blackstone has successfully completed the acquisition of Bluerock Residential Growth REIT at $24.25 per share, totaling $3.6 billion in cash. This acquisition aligns with Blackstone's strategy to expand its real estate portfolio. Additionally, Bluerock has spun off its single-family rental business into an externally managed REIT, Bluerock Homes Trust, which started trading on the NYSE American. The transaction was initially announced on December 20, 2021, and signifies strategic growth for both firms in the competitive real estate market.
This initiative builds on its Veterans Hiring Initiative, which has successfully hired over 100,000
Blackstone Credit announced increased distributions for its funds, with the Blackstone Private Credit Fund (BCRED) raising its monthly distribution to